Found 13 matching trials
Effects of Nutritional Fat on the Growth of Intestinal E. Coli
NARecent experiments in the lab of Prof. WD Hardt revealed, that in mice, 24 ...
Location
Institute of Microbiology (D-BIOL), ETH Zurich
E. Coli Nissle 1917 - Suspension for Infection Prophylaxis
PHASE3This study evaluates the long term effects of E. coli strain Nissle 1917 (E...
Location
Krankenhaus St. Elisabeth & St. Barbara
E. Coli Nissle in Oncology
PHASE3In patients with gastric or colorectal cancers, where a treatment with 5-Fl...
Location
Klinikum Ludwigsburg
Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis
PHASE2Due to the worldwide increasing prevalence of the allergic rhinoconjunctivi...
Location
Charité - Universitätsmedizin Berlin
Probiotics in the Treatment of Irritable Bowel Syndrome
NAThe aim of the present study is to assess the efficacy of two different pro...
Location
Volvat Medisinske Senter, Majorstuen
Open Label Trial of Nissle 1917
PHASE1Nissle 1917 is an E. coli based probiotic used in the Europe for close to 1...
Location
Nationwide Children's Hospital
Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children
N/ABackground:
Urinary tract infections (UTIs) are a common and costly cause ...
Location
Nationwide Children's Hospital
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
PHASE4Chronic constipation is a prevalent, burdensome gastrointestinal disorder w...
Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel Syndrome
EARLY_PHASE1Study SYNB8802-CP-002 is designed to assess safety, tolerability, and oxala...
Location
PPD, part of Thermo Fisher Scientific
Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.
PHASE4E.coli Nissle 1917 (Mutaflor®) is equivalent to mesalazine in preventing di...